Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic

Abstract

The Coronavirus disease 2019 (COVID-19) pandemic has led to a surge in need for alternative routes of administration of drugs for end of life and palliative care, particularly in community settings. Transmucosal routes include intranasal, buccal, sublingual and rectal. They are non-invasive routes for systemic drug delivery with the possibility of self-administration, or administration by family caregivers. In addition, their ability to offer rapid onset of action with reduced first-pass metabolism make them suitable for use in palliative and end-of-life care to provide fast relief of symptoms. This is particularly important in COVID-19, as patients can deteriorate rapidly. Despite the advantages, these routes of administration face challenges including a relatively small surface area for effective drug absorption, small volume of fluid for drug dissolution and the presence of a mucus barrier, thereby limiting the number of drugs that are suitable to be delivered through the transmucosal route. In this review, the merits, challenges and limitations of each of these transmucosal routes are discussed. The goals are to provide insights into using transmucosal drug delivery to bring about the best possible symptom management for patients at the end of life, and to inspire scientists to develop new delivery systems to provide effective symptom management for this group of patients.

[Retracted] Judicial Application of Punitive Damages for Ecological Environment Infringement in Civil Public Interest Litigation

“…“Tragedy of the commons” is a well-known phenomenon in economic circles, and it is also a widespread reality. In a foreign country, someone has done an interesting experiment, taking a piece of grassland, which is divided into several pieces and distributed to shepherds, but one piece is left in the middle as public land, which can be freely used by every shepherd [ 9 , 10 ]. As a result, sociologists found that over the course of a year, the grassland allocated to individuals was used in a planned and controlled manner, while the grassland used as public land was barren because of overgrazing.…”

Investigation of Cellular Interactions of Lipid-Structured Nanoparticles With Oral Mucosal Epithelial Cells

“…Hence, absorption of drugs is often difficult and depends strongly on the physicochemical properties including solubility, lipophilicity, molecular weight and others. ( Lam et al, 2020 ). Nanoparticles (NP) are one strategy for improving the delivery of e.g., poorly soluble or enzymatically degradable drugs into the oral mucosa.…”

Mucosal vaccine delivery: A focus on the breakthrough of specific barriers

“…As with other mucosal tissues, the surface of the oral mucosa is covered with mucus 37 . The buccal epithelial tissue which is 500‒800 μm thick, contains 40‒50 layers of cells 58 . The sublingual epithelial tissue, which is 100‒200 μm thick, contains 8‒12 layers of cells 59 .…”